These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Specific cyclooxygenase-2 inhibitors. Basis and options of a pharmacotherapeutic concept]. Hinz B; Brune K Anaesthesist; 2000 Nov; 49(11):964-71. PubMed ID: 11151817 [TBL] [Abstract][Full Text] [Related]
3. [Biological functions of cyclooxygenase 2: control of its expression and activity]. Jacquemin C J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase 2: from inflammation to carcinogenesis. Ristimäki A Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493 [TBL] [Abstract][Full Text] [Related]
11. Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation. Colville-Nash PR; Gilroy DW BioDrugs; 2001; 15(1):1-9. PubMed ID: 11437671 [TBL] [Abstract][Full Text] [Related]
12. The role of COX-2 in intestinal cancer. Williams C; Shattuck-Brandt RL; DuBois RN Ann N Y Acad Sci; 1999; 889():72-83. PubMed ID: 10668484 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Famaey JP Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). Taketo MM J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310 [TBL] [Abstract][Full Text] [Related]
15. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. Iñiguez MA; Punzón C; Fresno M J Immunol; 1999 Jul; 163(1):111-9. PubMed ID: 10384106 [TBL] [Abstract][Full Text] [Related]
16. [Clinical application of cyclooxygenase-2 inhibitors]. Dzielska-Olczak M; Olczak S Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270 [TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Marnett LJ; Kalgutkar AS Trends Pharmacol Sci; 1999 Nov; 20(11):465-9. PubMed ID: 10542447 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitors: a new approach to the therapy of ocular inflammation. Masferrer JL; Kulkarni PS Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S35-40. PubMed ID: 9154274 [TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors. van der Bijl P; van der Bijl P Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept. Celotti F; Laufer S Pharmacol Res; 2001 May; 43(5):429-36. PubMed ID: 11394934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]